Chemed マネジメント

マネジメント基準チェック /34

Chemedの CEO はKevin McNamaraで、 Aug1994年に任命され、の在任期間は 30.25年です。の年間総報酬は$ 12.63Mで、 12.7%給与と87.3%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.69%を直接所有しており、その価値は$ 59.23M 。経営陣と取締役会の平均在任期間はそれぞれ24.5年と15.5年です。

主要情報

Kevin McNamara

最高経営責任者

US$12.6m

報酬総額

CEO給与比率	12.7%
CEO在任期間	30.3yrs
CEOの所有権	0.7%
経営陣の平均在職期間	24.5yrs
取締役会の平均在任期間	15.5yrs

経営陣の近況

Recent updates

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

CEO報酬分析

Chemed の収益と比較して、Kevin McNamara の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Sep 30 2024	n/a	n/a	US$302m
Jun 30 2024	n/a	n/a	US$301m
Mar 31 2024	n/a	n/a	US$283m
Dec 31 2023	US$13m	US$2m	US$273m
Sep 30 2023	n/a	n/a	US$245m
Jun 30 2023	n/a	n/a	US$226m
Mar 31 2023	n/a	n/a	US$240m
Dec 31 2022	US$12m	US$1m	US$250m
Sep 30 2022	n/a	n/a	US$262m
Jun 30 2022	n/a	n/a	US$277m
Mar 31 2022	n/a	n/a	US$267m
Dec 31 2021	US$12m	US$1m	US$269m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	US$303m
Mar 31 2021	n/a	n/a	US$329m
Dec 31 2020	US$12m	US$1m	US$319m
Sep 30 2020	n/a	n/a	US$271m
Jun 30 2020	n/a	n/a	US$263m
Mar 31 2020	n/a	n/a	US$231m
Dec 31 2019	US$10m	US$1m	US$220m
Sep 30 2019	n/a	n/a	US$209m
Jun 30 2019	n/a	n/a	US$201m
Mar 31 2019	n/a	n/a	US$205m
Dec 31 2018	US$9m	US$1m	US$206m
Sep 30 2018	n/a	n/a	US$206m
Jun 30 2018	n/a	n/a	US$190m
Mar 31 2018	n/a	n/a	US$113m
Dec 31 2017	US$8m	US$1m	US$98m

報酬と市場: Kevinの総報酬 ($USD 12.63M ) は、 US市場 ($USD 7.79M ) の同規模の企業の平均を上回っています。

報酬と収益: Kevinの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Kevin McNamara (70 yo)

30.3yrs

在職期間

US$12,625,106

報酬

Mr. Kevin J. McNamara has been the Chief Executive Officer of Chemed Corporation since May 2001 and has been its President since August 2, 1994. Previously, Mr. McNamara served as an Executive Vice Preside...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Kevin McNamara	CEO, President & Director	30.3yrs	US$12.63m	0.69% $ 59.2m
Michael Witzeman	VP, Controller	12.5yrs	US$2.93m	0.025% $ 2.2m
Spencer Lee	Executive Vice President	24.5yrs	US$3.37m	0.13% $ 10.9m
Thomas Hutton	VP & Director	36.8yrs	データなし	0.56% $ 47.9m
Nicholas Westfall	Executive Vice President	8.4yrs	US$4.71m	0.041% $ 3.5m
Lisa Reinhard	VP, Chief Administrative Officer & Secretary	30yrs	データなし	データなし
Sherri Warner	Director of Investor Relations	no data	データなし	データなし
Brian Judkins	VP, Secretary & Chief Legal Officer	4.3yrs	データなし	0.0095% $ 812.2k
Nathan McNamara	VP & Chief Strategy Officer	no data	データなし	データなし

24.5yrs

平均在職期間

52.5yo

平均年齢

経験豊富な経営陣: CHEの経営陣は経験豊富で経験豊富です（平均在職期間は24.5年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Kevin McNamara	CEO, President & Director	37.8yrs	US$12.63m	0.69% $ 59.2m
Thomas Hutton	VP & Director	39.8yrs	データなし	0.56% $ 47.9m
Thomas Rice	Independent Director	15.5yrs	US$278.27k	0.040% $ 3.4m
Sandra Laney	Director Emeritus	15.5yrs	US$157.02k	データなし
Patrick Grace	Independent Director	28.8yrs	US$308.60k	0.022% $ 1.9m
George Walsh	Independent Chairman	29.8yrs	US$453.15k	0.023% $ 2.0m
Andrea Lindell	Independent Director	16.5yrs	US$272.77k	0.038% $ 3.3m
Christopher Heaney	Independent Director	4.5yrs	US$279.43k	0.014% $ 1.2m
Ron DeLyons	Independent Director	4.5yrs	US$278.27k	0.0093% $ 792.6k
John Mount	Independent Director	2.3yrs	US$278.27k	0.0044% $ 372.5k
Eileen McCarthy	Independent Director	1.5yrs	US$238.52k	0.0039% $ 329.8k

15.5yrs

平均在職期間

70yo

平均年齢

経験豊富なボード: CHEの取締役会は経験豊富で経験豊富です ( 15.5年の平均在任期間)。

Chemed マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

Executive Vice President recently sold US$566k worth of stock

CEO, President & Director recently sold US$1.2m worth of stock

Executive Vice President recently sold US$975k worth of stock

Executive Vice President exercised options and sold US$1.6m worth of stock

VP & Director notifies of intention to sell stock

Executive Vice President recently sold US$1.1m worth of stock

Recent updates

Executive Vice President recently sold US$566k worth of stock

Third quarter dividend of US$0.50 announced

Chemed Corporation Declares Quarterly Dividend, Payable on December 6, 2024

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Third quarter 2024 earnings: EPS misses analyst expectations

Now 29% undervalued after recent price drop

Chemed Corporation Revises Consolidated Earnings Guidance for the Full Year 2024

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

CEO, President & Director recently sold US$1.2m worth of stock

Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024

Executive Vice President recently sold US$975k worth of stock

Executive Vice President exercised options and sold US$1.6m worth of stock

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

VP & Director notifies of intention to sell stock

Second quarter dividend increased to US$0.50

Chemed Corporation Declares Quarterly Dividend, Payable on August 30, 2024

Executive Vice President recently sold US$1.1m worth of stock

Executive Vice President notifies of intention to sell stock

Second quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed Corporation to Report Q2, 2024 Results on Jul 24, 2024

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock

Independent Director recently sold US$160k worth of stock

Independent Director notifies of intention to sell stock

マネジメント基準チェック /34